Shigenobu Umeki

1.4k total citations
89 papers, 1.1k citations indexed

About

Shigenobu Umeki is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Shigenobu Umeki has authored 89 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Immunology. Recurrent topics in Shigenobu Umeki's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (12 papers), Lipid metabolism and biosynthesis (11 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). Shigenobu Umeki is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (12 papers), Lipid metabolism and biosynthesis (11 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). Shigenobu Umeki collaborates with scholars based in Japan and United States. Shigenobu Umeki's co-authors include Rinzō Soejima, Yoshinori Nozawa, Y Nozawa, Yoshihito Niki, K Sobue, Koichi Yagi, Michio Yazawa, Shiro Kakiuchi, Reiko Yamazaki and Hiroshi Kawane and has published in prestigious journals such as Journal of Biological Chemistry, PEDIATRICS and Biochemical and Biophysical Research Communications.

In The Last Decade

Shigenobu Umeki

87 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigenobu Umeki Japan 19 325 192 179 152 144 89 1.1k
Lester W. Schwartz United States 15 290 0.9× 210 1.1× 173 1.0× 180 1.2× 103 0.7× 28 966
Bo Odlind Sweden 21 287 0.9× 138 0.7× 189 1.1× 171 1.1× 102 0.7× 56 1.4k
Gunnar Carlin Sweden 17 370 1.1× 142 0.7× 74 0.4× 190 1.3× 89 0.6× 38 1.3k
Jonathan M. Gerrard United States 20 308 0.9× 158 0.8× 232 1.3× 125 0.8× 111 0.8× 41 1.4k
Arthur L. Sagone United States 23 408 1.3× 289 1.5× 172 1.0× 522 3.4× 153 1.1× 51 1.7k
J Benvéniste France 21 310 1.0× 171 0.9× 74 0.4× 263 1.7× 86 0.6× 45 1.0k
A. Schmitz Denmark 27 461 1.4× 137 0.7× 244 1.4× 106 0.7× 132 0.9× 64 2.4k
Rita Müller Switzerland 19 625 1.9× 203 1.1× 158 0.9× 152 1.0× 72 0.5× 49 1.8k
Marc B. Bailie United States 17 476 1.5× 384 2.0× 264 1.5× 378 2.5× 179 1.2× 44 2.0k
Akira Suwabe Japan 20 396 1.2× 135 0.7× 255 1.4× 79 0.5× 90 0.6× 67 1.1k

Countries citing papers authored by Shigenobu Umeki

Since Specialization
Citations

This map shows the geographic impact of Shigenobu Umeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigenobu Umeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigenobu Umeki more than expected).

Fields of papers citing papers by Shigenobu Umeki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigenobu Umeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigenobu Umeki. The network helps show where Shigenobu Umeki may publish in the future.

Co-authorship network of co-authors of Shigenobu Umeki

This figure shows the co-authorship network connecting the top 25 collaborators of Shigenobu Umeki. A scholar is included among the top collaborators of Shigenobu Umeki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigenobu Umeki. Shigenobu Umeki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Umeki, Shigenobu. (1994). Allergic Cycle: Relationships Between Asthma Allergic Rhinitis, and Atopic Dermatitis. Journal of Asthma. 31(1). 19–26. 8 indexed citations
2.
Umeki, Shigenobu. (1994). Prostaglandin E1 and analogs of prostacyclin influencing superoxide production by the human neutrophil nadph oxidase system. International Journal of Biochemistry. 26(8). 1003–1008. 6 indexed citations
3.
Umeki, Shigenobu. (1993). Anti-inflammatory Action of Erythromycin. CHEST Journal. 104(4). 1191–1193. 41 indexed citations
4.
Umeki, Shigenobu. (1991). Age-Related Changes in the Manifestations of Tuberculosis. Drugs & Aging. 1(6). 440–457. 4 indexed citations
5.
Umeki, Shigenobu. (1991). [Biochemical study on anti-inflammatory action of anti-allergic drugs--with regard to NADPH oxidase].. PubMed. 40(12). 1511–20. 2 indexed citations
6.
Umeki, Shigenobu, et al.. (1990). Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.. PubMed. 47(2). 103–7. 7 indexed citations
7.
Umeki, Shigenobu. (1990). Ampicillin serves as an electron donor. International Journal of Biochemistry. 22(11). 1291–1293. 6 indexed citations
8.
Umeki, Shigenobu & Rinzō Soejima. (1990). Hydrocortisone inhibits the respiratory burst oxidase from human neutrophils in whole-cell and cell-free systems. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1052(1). 211–215. 38 indexed citations
9.
Umeki, Shigenobu & Dorothy M. DeLisle. (1990). A microtechnique for neutrophil respiratory burst oxidase in a cell-free system—characterization of oxidase activation system. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 96(3). 461–464. 3 indexed citations
10.
Umeki, Shigenobu. (1989). Comparison of Younger and Elderly Patients with Pulmonary Tuberculosis. Respiration. 55(2). 75–83. 41 indexed citations
11.
Umeki, Shigenobu. (1989). [A case of Mycobacterium scrofulaceum lung infection occurring in old lung tuberculosis lesion].. PubMed. 64(1). 31–5. 1 indexed citations
12.
Umeki, Shigenobu, et al.. (1989). Urinastatin (Kunitz-Type Proteinase Inhibitor) Reducing Cisplatin Nephrotoxicity. The American Journal of the Medical Sciences. 298(4). 221–226. 17 indexed citations
13.
Umeki, Shigenobu. (1989). A new roentgenographic sign: The split eggshell sign for aortic arch aneurysms. The American Journal of Medicine. 86(3). 362–363. 1 indexed citations
14.
Umeki, Shigenobu, Rinzō Soejima, & Hiroshi Kawane. (1989). Young’s Syndrome Accompanied by Medullary Sponge Kidney. Respiration. 55(1). 60–64. 3 indexed citations
15.
Umeki, Shigenobu, et al.. (1989). Study on background factors associated with impaired glucose tolerance and/or diabetes mellitus. European Journal of Endocrinology. 120(6). 729–734. 21 indexed citations
16.
Niki, Yoshihito, Osamu Moriya, Shigenobu Umeki, et al.. (1988). BACTERIOLOGICAL AND CLINICAL STUDIES ON CS-807. 36(1). 529–534. 1 indexed citations
17.
Umeki, Shigenobu. (1988). Biochemical Abnormalities of the Serum in Anorexia Nervosa. The Journal of Nervous and Mental Disease. 176(8). 503–506. 48 indexed citations
18.
Umeki, Shigenobu. (1988). Primary Mucociliary Transport Failure. Respiration. 54(4). 220–225. 6 indexed citations
19.
Niki, Yoshihito, et al.. (1987). New Synthetic Quinolone Antibacterial Agents and Serum Concentration of Theophylline. CHEST Journal. 92(4). 663–669. 44 indexed citations
20.
Umeki, Shigenobu & Yoshinori Nozawa. (1986). Sterol Manipulation that Modulates the Alteration in Membrane Fluidity ofTetrahymena pyriformisduring Temperature Acclimation. Biological Chemistry Hoppe-Seyler. 367(1). 235–240. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026